263 related articles for article (PubMed ID: 3493719)
1. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
Wewers MD; Casolaro MA; Crystal RG
Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
[TBL] [Abstract][Full Text] [Related]
3. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
4. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
[TBL] [Abstract][Full Text] [Related]
6. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
[TBL] [Abstract][Full Text] [Related]
7. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
8. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton.
Curiel DT; Holmes MD; Okayama H; Brantly ML; Vogelmeier C; Travis WD; Stier LE; Perks WH; Crystal RG
J Biol Chem; 1989 Aug; 264(23):13938-45. PubMed ID: 2788166
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.
Curiel D; Brantly M; Curiel E; Stier L; Crystal RG
J Clin Invest; 1989 Apr; 83(4):1144-52. PubMed ID: 2539391
[TBL] [Abstract][Full Text] [Related]
13. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiency.
Straus SD; Fells GA; Wewers MD; Courtney M; Tessier LH; Tolstoshev P; Lecocq JP; Crystal RG
Biochem Biophys Res Commun; 1985 Aug; 130(3):1177-84. PubMed ID: 3896239
[TBL] [Abstract][Full Text] [Related]
15. Elastase inhibitors of the respiratory tract.
Stockley RA; Morrison HM
Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antitrypsin nonsense mutation associated with a retained truncated protein and reduced mRNA.
Lee J; Novoradovskaya N; Rundquist B; Redwine J; Saltini C; Brantly M
Mol Genet Metab; 1998 Apr; 63(4):270-80. PubMed ID: 9635295
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil elastase activity in cystic fibrosis serum.
Cantin AM; Lafrenaye S; Bégin RO
Pediatr Pulmonol; 1991; 11(3):249-53. PubMed ID: 1758746
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the sequence of the normal alpha-1-antitrypsin M3 allele and function of the M3 protein.
Curiel D; Laubach V; Vogelmeier C; Wurts L; Crystal RG
Am J Respir Cell Mol Biol; 1989 Dec; 1(6):471-7. PubMed ID: 2637759
[TBL] [Abstract][Full Text] [Related]
19. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
20. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]